Browsing Tag
Oncology
318 posts
Enhertu EU approval : Daiichi Sankyo, AstraZeneca get approval for HER2 low metastatic breast cancer
Daiichi Sankyo and AstraZeneca have received the approval of the European Union (EU) for their jointly developed Enhertu…
Takeda signs licensing deal for Hutchmed’s fruquintinib outside of China
Takeda Pharmaceutical will acquire an exclusive worldwide license, excluding China, of fruquintinib from Hutchmed (China) and its subsidiary…
Seagen gets FDA accelerated approval for tucatinib, trastuzumab combo for colorectal cancer
American biotechnology company Seagen (formerly Seattle Genetics) has received accelerated approval from the US Food and Drug Administration…
Regeneron gets Libtayo approval in Japan for advanced cervical cancer
Regeneron Pharmaceuticals has secured the approval of the Japanese Ministry of Health, Labor and Welfare (MHLW) to manufacture…
Merck and Mersana Therapeutics to co-develop new immunostimulatory ADCs
Merck has announced a collaboration with US-based Mersana Therapeutics to discover new antibody-drug conjugates (ADCs) by leveraging the…
AstraZeneca to acquire cell therapy company Neogene Therapeutics
AstraZeneca will acquire Neogene Therapeutics, a US-based clinical-stage biotechnology company, for a total consideration of up to $320…
Lupin subsidiary MedQuĂmica buys rights to nine drugs from Bausch Health
Lupin Limited said that MedQuĂmica IndĂşstria FarmacĂŞutica, its 100% subsidiary in Brazil, has agreed to acquire all rights…
FDA approves Janssen’s TECVAYLI for multiple myeloma treatment
The Janssen Pharmaceutical Companies, a subsidiary of Johnson & Johnson, announced the US Food and Drug Administration’s approval…
Alembic Pharmaceuticals gets FDA final approval for Paclitaxel Injection USP
Alembic Pharmaceuticals Limited has secured final approval for its abbreviated new drug application (ANDA) for Paclitaxel Injection USP,…
Clinical-stage pharma firms Ayala Pharmaceuticals, Advaxis sign merger deal
Ayala Pharmaceuticals, a Nasdaq-listed clinical-stage oncology company, has entered into a merger deal with New Jersey-based biotech company…